Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]: Side Effects & Safety Data for 5 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] includes 5 drugs with a combined 287,935 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
5
Drugs in Class
287,935
Combined Reports
All Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| TIRZEPATIDE | Zepbound | 99,893 | 455 | 5,527 | 0.5% |
| DULAGLUTIDE | Trulicity | 74,022 | 1,054 | 6,536 | 1.4% |
| SEMAGLUTIDE | WEGOVY | 59,604 | 792 | 11,258 | 1.3% |
| EXENATIDE | Exenatide | 31,297 | 1,228 | 2,512 | 3.9% |
| LIRAGLUTIDE | Victoza | 23,119 | 994 | 4,819 | 4.3% |
Common Side Effects in Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Nausea | 34,895 | 190 |
| Incorrect dose administered | 30,500 | 7 |
| Injection site pain | 25,998 | 2 |
| Vomiting | 19,062 | 165 |
| Blood glucose increased | 18,493 | 56 |
| Diarrhoea | 18,305 | 125 |
| Off label use | 15,521 | 78 |
| Injection site haemorrhage | 13,442 | 1 |
| Weight decreased | 11,561 | 111 |
| Decreased appetite | 11,119 | 125 |